About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
MRAI
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Marpai announces key financial agreements
- Accelerate Diagnostics, Silk Road Medical among healthcare movers
- Marpai CEO buys 1.1M shares of the company - filing
- Marpai appoints John Powers as its CEO
- Marpai regains compliance with Nasdaq minimum bid price requirement
- Marpai GAAP EPS of -$0.98 misses by $0.57, revenue of $8.7M beats by $0.29M
- Marpai appoints Damien Lamendola as its new CEO
- Marpai GAAP EPS of -$1.10, revenue of $10.04M
- Marpai still sees Q2 revenue $9.5M-$9.8M vs. consensus of $9.51M
- Marpai announces 4 to 1 reverse stock split
- Marpai reports Q1 results, reaffirms FY 2023 revenue guidance
- Marpai closes $7.4M equity offering
- Marpai falls 29% after pricing equity offering
- Marpai proposes stock offering, shares slump ~21% after hours
- Marpai GAAP EPS of -$0.41 beats by $0.09, revenue of $7.6M beats by $0.55M
- Marpai hires COO
- Marpai GAAP EPS of -$0.28, revenue of $4.94M
- Marpai rallies after directors buy shares
- Marpai GAAP EPS of -$0.34 misses by $0.04, revenue of $5.6M beats by $0.25M
- Marpai to acquire Maestro Health for $22.1M